欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/V/0301/001
药品名称Avishield IB GI-13, lyophilisate for oculonasal suspension/use in drinking water for chickens
活性成分
    • avian infectious bronchitis virus 2.7 log10 EID50/do
剂型Lyophilisate for oculonasal suspension/use in drinking water
上市许可持有人GENERA Inc. Svetonedeljska cesta 2, Kalinovica 10436 Rakov Potok Croatia
参考成员国 - 产品名称Netherlands (NL)
Avishield IB GI-13
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
      Avishield IB GI-13
    • United Kingdom (Northern Ireland) (XI)
      Avishield IB Variant, lyophilisate for oculonasal suspension/use in drinking water for chickens
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Avishield IB GI-13 liofilizāts okulonazālas suspensijas pagatavošanai/lietošanai ar dzeramo ūdeni vistām
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Czechia (CZ)
      Avishield IB GI-13, lyofilizát pro okulonazální suspenzi / pro podání v pitné vodě pro kura domácího
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2020/02/05
最近更新日期2024/02/29
药物ATC编码
    • QI01AD07 avian infectious bronchitis virus
申请类型
  • TypeLevel1:food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase